Accelerate Diagnostics Revenue, Profits - AXDX Annual Income Statement

Add to My Stocks
$22.4 $0.3 (1.32%) AXDX stock closing price Sep 25, 2017 (Closing)

Looking at financial statements, along with the Accelerate Diagnostics stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. ξ The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Like any other income statement, the AXDX income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YoY revenue growth of $0.1M when compared to the same period in the past. Along with Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow, Accelerate Diagnostics profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-45.49M YoY and 2016 revenue is $0.24M. Accelerate Diagnostics revenue for 2016 is 0.24M. View revenue and profit details for latest and last 10 financial years.

show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Accelerate Diagnostics Net Sales or Revenues
0.24M0.14M0.12M0.04M-1.12M2.24M1.26M0.47M0.18M
Cost Of Goods Sold (COGS)--------0.01M0.05M
Accelerate Diagnostics Gross Profit
0.24M0.14M0.12M0.04M-1.12M2.24M1.26M0.46M0.12M
Research & Development Expense28.19M26.02M20.05M10.67M-0.45M0.5M0.74M0.88M0.99M
Selling General & Admin Expense36.2M17.88M10.69M4.31M-0.81M0.87M0.93M1.01M0.93M
Income Before Depreciation Depletion Amortization-64.15M-43.75M-30.62M-14.93M--0.15M0.87M-0.4M-1.43M-1.8M
Depreciation Depletion Amortization2.35M1.79M0.89M0.37M-0.25M0.26M0.27M0.29M0.31M
Non Operating Income0.41M0.07M0.06M0.02M-0.03M0.02M-0.03M0.04M0.19M
Interest Expense0.02M0.02M0.01M-------
Accelerate Diagnostics Pretax Income
-66.1M-45.49M-31.46M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Provision for Income Taxes0.26M--0.52M-------
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-66.37M-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Extraordinary Items & Discontinued Operations----------
Accelerate Diagnostics Net Income (Profit/Loss)
-66.37M-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Average Shares used to compute Diluted EPS51.28M45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Average Shares used to compute Basic EPS51.28M45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Income Before Nonrecurring Items-66.37M-45.5M-30.93M-15.28M-5.31M-0.38M0.64M-0.71M-1.68M-1.92M
Income from Nonrecurring Items----------
Accelerate Diagnostics Earnings Per Share Basic Net
-1.29-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Accelerate Diagnostics Earnings Per Share Diluted Net
-1.29-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
EPS Diluted Before Nonrecurring Items-1.29-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Accelerate Diagnostics stock analysis. An investor must check the following items in an income statement:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Accelerate Diagnostics revenue chart) implies that the company is growing, which has been the case with Accelerate Diagnostics. One must stay away from stocks whose revenues or sales are declining.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $0.24M - other expenses = $-66.37M for AXDX stock. An improving bottomline implies that the company is growing its profits.
The income statement is also called statement of revenue and expense. The AXDX financials along with Accelerate Diagnostics historical stock prices provide a lot of details about the firm .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
952.36
Dividend Yield
0%